ev3 to Acquire Chestnut Medical Technologies
ev3 signed a definitive agreement to acquire Chestnut Medical Technologies, the developer of the Pipeline Embolization Device for cerebral aneurysm repair. The transaction will add unique, paradigm shifting technology to ev3 neurovascular franchise.
IN3 Investors Conference Paris
Presented today at IN3 Investors Conference in Paris on behalf of Cardiatis. I’ve got to admit, Cardiatis platform technology really rocks. Noureddine Frid, the lead entrepreneur and inventor has devevlop the first universally applicable endovascular aneurysm repair stent and the concept is testing well in clinical trials.
The presentation was simple this time, I covered the 5,000 year history of aneurysm repair in a couple of slides, explained how Cardiatis platform technology differs from current existing endovascular devices for aneurysm repair and then gave the coupe de grace:
“It is sufficient to say that in the field of aneurysm treatment Cardiatis is making history. We have a new answer to endovascular aneurysm repair and it is simple, it is elegant and it works.“
Quite an interest we generated among attending VCs and the industry brass. The Hilton was ok and Paris lovely as always.
Balt Neuroendovascular Business
Balt, a French privately held company specialized in the manufacture and distribution of intracerebral micro catheters, realized over US$17 million in revenue for 2007 mainly in the neuro-endovascular field.
Balt range of products include the LEO nitinol self expandable stent launched in 2003 for intra cranial indications, the VASCO braided microcatheter, the BOA balloon expandable Platinum Stent launched in 2000 for peripheral and intra cranial angioplasties, the Channel balloon expandable Platinum Stent for cerebral stenosis, the CORAIL balloon tipped guiding catheter and the CATCH thrombus retrieval system.
Balt has recently launched the Silk, a nitinol braided self expandable stent for cerebral aneurysm repair resorption, in Europe and on international markets.